Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high995.0 26/07/17
52 week low615.1 17/08/16
52 week change 308.0 (45.63%)
4 week volume5,717,605 30/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - Numis issues a broker note on Clinigen Group

Numis today downgrades its investment rating on Clinigen Group (LON:CLIN) to add (from buy) and set its price target a...

Clinigen gross profits up 22%

Clinigen Group said it expected its gross profits for the year ended 30 June to be up 22% driven by a combination of organ...

Year End Trading Update

RNS Number: 3083L Clinigen Group plc 18 July 2017 18 July 2017 Year end trading update Strong full year performance with profits up over 20% Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, today provides a trading update for the 12 months ended 30 June 2017. Highlights Gross profit* expected to be up 2...

Buy, hold, sell: Old Mutual UK Smaller Companies

Daniel Nickols, manager of the Old Mutual UK Smaller Companies fund, tells Marina Gerner which stocks he has been b...

Clinigen and Cumberland Pharma obtain FDA approval for Totect

Clinigen Group and Cumberland Pharmaceuticals have announced they have obtained FDA approval for Totect (dexrazo...

Clinigen and Cumberland: FDA approval for Totect

RNS Number: 6070K Clinigen Group plc 10 July 2017 RNS Reach 10 July 2017 Clinigen and Cumberland Pharmaceuticals obtain FDA approval for Totect in the U.S. Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company and Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX, 'Cumberland'), a U.S. specialty pharma...

Clinigen options exercised

Clinigen Group has issued 488 ordinary shares following the exercise of options. At 9:31am: (LON:CLIN) Clinigen Group sha...

Issue of Equity

RNS Number: 3479K Clinigen Group plc 07 July 2017 7 July 2017 Issue of Equity Clinigen Group plc (the "Group", AIM: CLIN) announces that it has made an application for the admission to trading on AIM of 488 ordinary shares of 0.1 pence each in the Group (the "New Ordinary Shares"), which have been issued to satisfy the exercise of share options and rank par...

Fundamental DataMore

P/E ratio82.605
EPS11.9
Dividend yield0.407 %

Equity Research (CLIN)

Clinigen Group Plc
16/03/2017
Magnolia Petroleum (MAGP.L) 0.14p £2.45m US onshore focused oil and gas exploration and production company, announced the results of an independent Reserves Report.  The Report, which is part of the...
edison investment research
Clinigen Group Plc
01/03/2016
Edison Investment Research is terminating coverage on Clinigen Group (CLIN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be...
edison investment research
Clinigen Group Plc
25/01/2016
Clinigen’s H116 trading statement suggests its business is performing to plan, taking into account some revenue deferrals to H2. The integration of Idis and Link, which we expect to boost its...

Latest discussion posts More

  • NEW ARTICLE: Buy, hold, sell: Old Mutual UK Smaller Companies

    "Daniel Nickols, manager of the Old Mutual UK Smaller Companies fund, tells Marina Gerner which stocks he has been buying, selling and holding recently.Daniel Nickols has been ...
    17-Jul-2017
    II Editor
  • Re: Share Price

    too many large share sales by directors for my liking
    30-Jun-2017
    gravy
  • Re: Share Price

    Maybe it is is down to President Trump trying to remove obama care with his new healthcare bill, voting later today.
    23-Mar-2017
    bushwhacker

Users' HoldingsMore

Users who hold Clinigen Group also hold..
LLOYDS GRP.20%
GLAXOSMITHKLINE20%
TELFORD HOMES19%
RDS 'B'17%
BP17%

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN